Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

被引：5116

作者：

Fauser, BCJM ^{[1
]}

Chang, J ^{[1
]}

Azziz, R ^{[1
]}

Legro, R ^{[1
]}

Dewailly, D ^{[1
]}

Franks, S ^{[1
]}

Tarlatzis, BC ^{[1
]}

Fauser, B ^{[1
]}

Balen, A ^{[1
]}

Bouchard, P ^{[1
]}

Dahlgren, E ^{[1
]}

Devoto, L ^{[1
]}

Diamanti, E ^{[1
]}

Dunaif, A ^{[1
]}

Filicori, M ^{[1
]}

Homburg, R ^{[1
]}

Ibanez, L ^{[1
]}

Laven, J ^{[1
]}

Magoffin, D ^{[1
]}

Nestler, J ^{[1
]}

Norman, RJ ^{[1
]}

Pasquali, R ^{[1
]}

Pugeat, M ^{[1
]}

Strauss, J ^{[1
]}

Tan, S ^{[1
]}

Taylor, A ^{[1
]}

Wild, R ^{[1
]}

Wild, S ^{[1
]}

Ehrmann, D ^{[1
]}

Lobo, R ^{[1
]}

机构：

[1] Erasmus MC, Ctr Reprod Med, NL-3015 GD Rotterdam, Netherlands

来源：

HUMAN REPRODUCTION | 2004年 / 19卷 / 01期

关键词：

diagnostic criteria; long-term health risks; polycystic ovary syndrome; revised; 2003; consensus;

D O I：

10.1093/humrep/deh098

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include: menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.

引用

页码：41 / 47

页数：7

共 94 条

[1]

PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J].

ADAMS, J ;

POLSON, DW ;

FRANKS, S .

BRITISH MEDICAL JOURNAL, 1986, 293 (6543) :355-359

[2]

Meta-analysis of recombinant versus urinary-derived FSH: an update [J].

Al-Inany, H ;

Aboulghar, M ;

Mansour, R ;

Serour, G .

HUMAN REPRODUCTION, 2003, 18 (02) :305-313

[3]

[Anonymous], 1995, Hum Reprod, V10, P1549

[4]

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].

Asunción, M ;

Calvo, RM ;

San Millán, JL ;

Sancho, J ;

Avila, S ;

Escobar-Morreale, HF .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438

[5]

Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study [J].

Azziz, R ;

Hincapie, LA ;

Knochenhauer, ES ;

Dewailly, D ;

Fox, L ;

Boots, LR .

FERTILITY AND STERILITY, 1999, 72 (05) :915-925

[6]

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].

Azziz, R ;

Ehrmann, D ;

Legro, RS ;

Whitcomb, RW ;

Hanley, R ;

Fereshetian, AG ;

O'Keefe, M ;

Ghazzi, MN .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632

[7]

MISCARRIAGE RATES FOLLOWING INVITRO FERTILIZATION ARE INCREASED IN WOMEN WITH POLYCYSTIC OVARIES AND REDUCED BY PITUITARY DESENSITIZATION WITH BUSERELIN [J].

BALEN, AH ;

TAN, SL ;

MACDOUGALL, J ;

JACOBS, HS .

HUMAN REPRODUCTION, 1993, 8 (06) :959-964

[8]

POLYCYSTIC-OVARY-SYNDROME - THE SPECTRUM OF THE DISORDER IN 1741 PATIENTS [J].

BALEN, AH ;

CONWAY, GS ;

KALTSAS, G ;

TECHATRAISAK, K ;

MANNING, PJ ;

WEST, C ;

JACOBS, HS .

HUMAN REPRODUCTION, 1995, 10 (08) :2107-2111

[9]

BALEN AH, 2003, IN PRESS HUM REPROD

[10]

Bili, H ;

Laven, J ;

Imani, B ;

Eijkemans, MJC ;

Fauser, BCJM .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (06) :749-755

← 1 2 3 4 5 6 7 8 9 10 →